Welcome to TargetRX Atlas.

TargetRX Atlas is a comprehensive database meticulously curated to encompass experimentally validated relationships between diseases, coding RNA, and drug targets. This resource is specifically designed to enhance the understanding of the intricate connections between drugs and target genes in human diseases, as well as to facilitate the identification of potential therapeutic targets. The latest iteration of TargetRX Atlas incorporates data from 1,925 scientific articles indexed in PubMed, which substantiate the role of drugs acting on mRNA in disease treatment. Additionally, it includes 1,881 articles that document the impact of mRNA on the progression of diseases. The database currently features over 13,000 entries, encompassing 2,000 mRNAs, 1,100 drugs, and 600 diseases, thereby providing a robust platform for researchers in the field of pharmacological research and disease treatment.

TargetRX Atlas features include: I. Pioneering integration of mRNA-drug associations in human diseases. II. Comprehensive, updated data on diseases, drugs, and mRNA. III. Identification of therapeutic targets for disease treatment. IV. A unified resource integrating mRNA, drug, disease data, and therapeutic targets to advance drug treatment strategies.

We highly recommend Google Chrome or Safari browser to have a better experience on TargetRX Atlas.